Masahiro Ito

5PUBLICATIONS
10CO-AUTHORS
Molecular targetsBiologically active moleculesIndustrial molecular engineering of nucleic acids and proteinsRehabilitation engineeringMedical robotics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 14, 2026
Discovery of CTX-439: A Potent and Selective CDK12 Inhibitor as a Prospective Anti-Cancer Drug.

|Aug 02, 2018
Discovery of 3-Benzyl-1-( trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors.

Masahiro Ito, Toshio Tanaka, Akinori Toita

|Jun 07, 2017
Discovery of Allosteric Inhibitors Targeting the Spliceosomal RNA Helicase Brr2.

Misa Iwatani-Yoshihara, Masahiro Ito, Michael G Klein

|Apr 26, 2017
Discovery and Characterization of a Eukaryotic Initiation Factor 4A-3-Selective Inhibitor That Suppresses Nonsense-Mediated mRNA Decay.

Misa Iwatani-Yoshihara, Masahiro Ito, Yoshihiro Ishibashi

|Mar 31, 2017
Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 Inhibitors.

Masahiro Ito, Toshio Tanaka, Douglas R Cary

Pageof 1

Frequent Collaborators

2 joint publications

Douglas R Cary

2 joint publications

Misa Iwatani-Yoshihara

2 joint publications

Hironori Kokubo

2 joint publications

Tomoya Sameshima